Therefore, targeting MYC-regulated miRNAs appears to represent a suitable strategy to interfere with MYC-dependent cancers, although it may be difficult to deliver miRNA mimetics into the tumor tissue of interest without losing their efficacy due to premature degradation. Here, MYC is linked to neoplasm.